1/30
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No study sessions yet.
are cell contents liberated in apoptosis
no (but is in necrosis)
so doesnt invoke immune response
how are apoptotic cells removed
engulfed partly or whole by phagocyte
extracellular/extrinsic pathway to activate apop
signalling from death receptors on cell surface
intacellular/intrinsic activation of apop
dsDNA breaks
p53
UV radiation
hypoxia
what are caspases
cyc-catalysed aspartate targeting proteases
induce apoptosis
activation of caspases
exp as pro-caspases
activated by cleavage between large and small domains, and cleave N term prodomains off, allowing large and small subunits to heterodimerise, then form tetramer together
caspase cascade
are caspases highly specific
yes, recognise and degrade v few proteins (a proteases)
initiator vs executioner caspases
8,9 and 10: activate a cascade that results in activation of executioner caspases
3 and 7 are executioner, induce cell killing
what activates initiator caspases 8 and 10
signalling via death receptors (via FADD)
what activates caspase 9
activated by APAF-1, cytochrome c and ATP via CARD domain (intracellular pathways)
what are caspase inhibitors
inhib caspase by binding to catalytic site, so inhib apoptosis
e.g. c-FLIP inhibs casp 8 (therefore inhib executioner capsase activation)
effect of overexpression of c-FLIP in tumours
prev caspase 8 activation, so limit executioner caspase activation
how do executioner caspases induce apop
cleave cyto proteins and nuclear lamina
role of FasL and TRAIL
both bind to Fas and TRAIL death receptors, causing receptor to trimerise, which recruits FADD in cyto (via death domain cluster)
FADD is adaptor protein between receptor and caspase 8 and 10
(form death induced signalling complex, DISC)
TRAIL receptors aka death receptor 4 and 5
what cells contain FasL and TRAIL
killer lymphocytes
mechanisms to prevent signalling via death receptors (external)
soluble and membrane decoy receptors, intracellular activators and inhibitors
intrinsic pathway that activates apoptosis
cytochrome c rel from mitochrondria
cytc binds Apaf1
causes exchange of ADP for GTP which triggers Apaf1 to assemble into apoptosome (many Apaf1 int. via their CARD domain)
apoptosome recruits procaspase9 (also has CARD domain) causing its cleavage
BCL-2 family (proteins)
anti apoptotic
found in B cell lymphomas
are mito memb proteins
what causes cytochrome c release from mito
normally have inactive BH123 proteins (BCL-2 proteins with BH1,2,3 so are proapop) in mito memb that are prev from dimerising by antiapop BLC-2 protein (have BH1,2,3,4) in cyto
apoptotic stimulus activates proapop BH3-only BCL-2 proteins in cyto that cause inhibition of the antipop BCL-2 proteins, allowing BH123 proteins to dimerise in memb, act as pore that lets cyt c exit mito
(anti-IAP rel too)
role of inhibitors of apoptosis
inhib apoptosis e.g. c-FLIP
bind caspases so inactivate them
often upreg in cancers
role of anti-IAPs and where they come from
bind and therefore inhib IAP
get rel from mito with cyt c
what are telomeres
termini of eukaryotic linear chromosomes
repeat 6 nt seq TTAGGG
approx 12 kb at e ach end
most of telomere is dsDNA but has G rich single strand that forms terminal 3’ overhang
noncoding
specific proteins bind it
structure of a telomere
TTAGGG repeat, with terminal 3’ overgang (G-rich), invades dsDNA to form T-loop
bound by many proteins
function of telomeres
protect chromosome ends from shortening
prev chromosome ends from becoming entangled and adhering to eachother (T-loop)
assist in pairing of homologous chromosomes during prophase of meiosis I
how much of telomere is lost each mitosis
100 bp
(16 × 16 repeats)
how is DNA synth
use RNA primer to synth okazaki fragments
remove primer, pol synth between fragments and ligate together
always get 3’ overhang
what is telomerase
a ribonucleoprotein complex
synth telomeres from RNA template (using activity of TERT domain (telomerase reverse transcriptase, so is a specialised reverse transcriptase)
RNA template is the TERC domain (telomerase RNA component) (451 nt in humans)
that provs AAUCCC template
mech of action of telomerase
binds, elongation, translocation (moves along), so can elongate further. does it in 2 syth steps, where binds 3’ overhang and syth some of telomere, it then moves and binds this new DNA that it can then extend from
where is telomerase found
germline cells inc. embryonic stem cells
certain, poss. all adult stem cells and progenitor cells (so can keep proliferating)
cancer cells
unicellular eukaryotes like tetrahymena
what eventually blocks mitotic division
shortening of telomeres, prev genomic instability (lose coding DNA each rep)
but in cancer, have telomerase making them immortal